An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors
In the recent cancer treatment, B-Raf kinase is one of key targets. Nowadays, a group of imidazopyridines as B-Raf kinase inhibitors have been reported. In order to investigate the interaction between this group of inhibitors and B-Raf kinase, molecular docking, molecular dynamic (MD) simulation and...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/16/11/26026 |
id |
doaj-70eb68b5f73e4ceaa06da0d6a20fc879 |
---|---|
record_format |
Article |
spelling |
doaj-70eb68b5f73e4ceaa06da0d6a20fc8792020-11-25T01:13:01ZengMDPI AGInternational Journal of Molecular Sciences1422-00672015-11-011611273502736110.3390/ijms161126026ijms161126026An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase InhibitorsHuiding Xie0Yupeng Li1Fang Yu2Xiaoguang Xie3Kaixiong Qiu4Jijun Fu5Department of Chemistry, Yunnan University, Kunming 650091, ChinaDepartment of Chemistry, School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, ChinaDepartment of Chemistry, School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, ChinaDepartment of Chemistry, Yunnan University, Kunming 650091, ChinaDepartment of Chemistry, School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, ChinaDepartment of Chemistry, School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, ChinaIn the recent cancer treatment, B-Raf kinase is one of key targets. Nowadays, a group of imidazopyridines as B-Raf kinase inhibitors have been reported. In order to investigate the interaction between this group of inhibitors and B-Raf kinase, molecular docking, molecular dynamic (MD) simulation and binding free energy (ΔGbind) calculation were performed in this work. Molecular docking was carried out to identify the key residues in the binding site, and MD simulations were performed to determine the detail binding mode. The results obtained from MD simulation reveal that the binding site is stable during the MD simulations, and some hydrogen bonds (H-bonds) in MD simulations are different from H-bonds in the docking mode. Based on the obtained MD trajectories, ΔGbind was computed by using Molecular Mechanics Generalized Born Surface Area (MM-GBSA), and the obtained energies are consistent with the activities. An energetic analysis reveals that both electrostatic and van der Waals contributions are important to ΔGbind, and the unfavorable polar solvation contribution results in the instability of the inhibitor with the lowest activity. These results are expected to understand the binding between B-Raf and imidazopyridines and provide some useful information to design potential B-Raf inhibitors.http://www.mdpi.com/1422-0067/16/11/26026imidazopyridineB-Raf kinasemolecular dockingmolecular dynamic simulation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Huiding Xie Yupeng Li Fang Yu Xiaoguang Xie Kaixiong Qiu Jijun Fu |
spellingShingle |
Huiding Xie Yupeng Li Fang Yu Xiaoguang Xie Kaixiong Qiu Jijun Fu An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors International Journal of Molecular Sciences imidazopyridine B-Raf kinase molecular docking molecular dynamic simulation |
author_facet |
Huiding Xie Yupeng Li Fang Yu Xiaoguang Xie Kaixiong Qiu Jijun Fu |
author_sort |
Huiding Xie |
title |
An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors |
title_short |
An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors |
title_full |
An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors |
title_fullStr |
An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors |
title_full_unstemmed |
An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors |
title_sort |
investigation of molecular docking and molecular dynamic simulation on imidazopyridines as b-raf kinase inhibitors |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2015-11-01 |
description |
In the recent cancer treatment, B-Raf kinase is one of key targets. Nowadays, a group of imidazopyridines as B-Raf kinase inhibitors have been reported. In order to investigate the interaction between this group of inhibitors and B-Raf kinase, molecular docking, molecular dynamic (MD) simulation and binding free energy (ΔGbind) calculation were performed in this work. Molecular docking was carried out to identify the key residues in the binding site, and MD simulations were performed to determine the detail binding mode. The results obtained from MD simulation reveal that the binding site is stable during the MD simulations, and some hydrogen bonds (H-bonds) in MD simulations are different from H-bonds in the docking mode. Based on the obtained MD trajectories, ΔGbind was computed by using Molecular Mechanics Generalized Born Surface Area (MM-GBSA), and the obtained energies are consistent with the activities. An energetic analysis reveals that both electrostatic and van der Waals contributions are important to ΔGbind, and the unfavorable polar solvation contribution results in the instability of the inhibitor with the lowest activity. These results are expected to understand the binding between B-Raf and imidazopyridines and provide some useful information to design potential B-Raf inhibitors. |
topic |
imidazopyridine B-Raf kinase molecular docking molecular dynamic simulation |
url |
http://www.mdpi.com/1422-0067/16/11/26026 |
work_keys_str_mv |
AT huidingxie aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT yupengli aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT fangyu aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT xiaoguangxie aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT kaixiongqiu aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT jijunfu aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT huidingxie investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT yupengli investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT fangyu investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT xiaoguangxie investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT kaixiongqiu investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT jijunfu investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors |
_version_ |
1725163744919552000 |